Empagliflozin/Metformin Tablets 12.5/850 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
MFDS item code 202302640 · Approved 2023.09.05
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help improve glycemic control in adults with Type 2 diabetes through the combined administration of empagliflozin and metformin. It is particularly administered in cases of adults with Type 2 diabetes whose blood glucose is not adequately controlled and who are at risk of cardiovascular events.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication is an antidiabetic agent that helps lower blood sugar. It may cause a rare side effect known as lactic acidosis, which can lead to a dangerous condition due to excessive lactate build-up in the body, so caution is advised. There is a risk of hypoglycemia when taken with insulin or other antidiabetic medications, so blood glucose levels should be monitored closely. Patients with severely impaired renal function, certain acute illnesses, Type 1 diabetes, or women who are pregnant or breastfeeding should not take this medication. Prior to and after examinations using iodinated contrast agents, this medication should be temporarily discontinued to prevent risks of worsening renal function and lactic acidosis. Regular kidney function tests should be performed during the use of this medication, and it should be suspended or used carefully before and after dehydration, severe infections, or surgery. This medication can increase urination and may elevate the risk of urinary tract infections or genital infections, so consult a doctor if symptoms appear. Additionally, various side effects such as gastrointestinal disturbances, hypoglycemia, liver function abnormalities, skin rashes, etc., may occur; any unusual symptoms should be reported. Elderly patients or those at risk of fluid loss should take special care. Alcohol consumption may increase the risk of lactic acidosis, so it should be avoided. Women who are pregnant, may become pregnant, or are breastfeeding are advised not to use this medication. In case of overdose, hemodialysis might be necessary; thus, adherence to the prescribed dose and the doctor's instructions is crucial. The safety and efficacy of this medication in children have not been established, and it is not recommended for individuals under 18 years of age. Regular blood tests and kidney function tests should be conducted during the course of this medication, with attention paid to signs of hypoglycemia or infection. Caution is needed when driving or operating machinery during the use of this medication, depending on symptoms.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect from air and moisture. It is advisable to maintain the storage temperature between 1 and 30 degrees Celsius.
Pink-tinged white, biconvex oval film-coated tablets
60 tablets/bottle, 60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Daewon Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.